Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancerJames E Lester, David Dodwell, Omprakash P Purohit, et al.Endocrine-Related Cancer|January 14, 2014
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell lineFaith Nutter, Ingunn Holen, Hannah K Brown, et al.Journal of Bone Oncology|February 25, 2016
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trialsRobert E Coleman, Allan Lipton, Luis Costa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04)Emma J Rathbone, Janet E Brown, Helen C Marshall, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2013
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidRoger von Moos, Jean-Jacques Body, Blair Egerdie, et al.Journal of the National Cancer Institute|January 14, 2016
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and TreatmentJules A Westbrook, David A Cairns, Jianhe Peng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survivalNaveen S Vasudev, Janet E Brown, Sarah R Brown, et al.BJU International|July 12, 2023
Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019Samantha Conroy, James W F Catto, Axel Bex, et al.Journal of Bone Oncology|September 30, 2020
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert groupJanet E Brown, Catherine Handforth, Juliet E Compston, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2015
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison T Stopeck, Karim Fizazi, Jean-Jacques Body, et al.Pageof 6